Press Event: MD Anderson immunologist Jim Allison awarded Nobel Prize

T cell discoveries led to game-changing treatment revolutionizing cancer care

Jim Allison, Ph.D., chair of Immunology and executive director of the immunotherapy platform at The University of Texas MD Anderson Cancer Center, today was awarded the 2018 Nobel Prize in Physiology or Medicine for launching an effective new way to attack cancer by treating the immune system rather than the tumor. 
“By stimulating the ability of our immune system to attack tumor cells, this year’s Nobel Prize  laureates have established an entirely new principle for cancer therapy,” the  Nobel Assembly of Karolinska Institute in Stockholm noted in announcing the award to Allison and Tasuku Honjo, M.D., Ph.D., of  Kyoto University in Japan.
Allison spoke at a press conference in New York today to comment on this prestigious recognition and answer questions about his pivotal research in immunotherapy. A full video of the press conference is available below and a full transcript is available here.